uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Growth Factor Changes in Cerebrospinal Fluid of Children with Mental Retardation before and after Neural Precursor Cell Transplantation
Navy Gen Hosp, Dept Pediat, 6 Fucheng Rd, Beijing 100048, Peoples R China.
Navy Gen Hosp, Dept Pediat, 6 Fucheng Rd, Beijing 100048, Peoples R China.
Navy Gen Hosp, Dept Pediat, 6 Fucheng Rd, Beijing 100048, Peoples R China.
Navy Gen Hosp, Dept Pediat, 6 Fucheng Rd, Beijing 100048, Peoples R China.
Show others and affiliations
2018 (English)In: CNS & Neurological Disorders: Drug Targets, ISSN 1871-5273, E-ISSN 1996-3181, Vol. 17, no 2, p. 98-105Article in journal (Refereed) Published
Abstract [en]

Objective: To investigate growth factor changes in cerebrospinal fluid (CSF) of children with mental retardation (MR) before and after neural precursor cell transplantation (NPCT), in an attempt to provide experimental support for the clinical treatment of MR with NPCT.

Methods: The study comprised of 28 MR children who received twice NPCT in our hospital. CSF was collected at both times of NPCT to assess growth factors by ELISA. In addition, the content of insulin-like growth factor 1 (IGF-1) in CSF was assayed to determine possible correlations between IGF-1 changes and the short-term therapeutic effect of NPCT.

Results: Of all the growth factors detected in CSF, only IGF-1 was increased significantly after NPCT (P<0.05). Fifteen of the twenty-eight MR children achieved short-term therapeutic efficacy, whereby the content of IGF-1 after NPCT was significantly higher than that before NPCT (P<0.05). There was no difference in IGF-1 content before and after NPCT in the remaining 13 MR children without short-term therapeutic effect (P=0.657). There was a significant difference in IGF-change between the two groups of patients (P<0.05).

Conclusion: IGF-1 may be one of the mechanisms contributing to the therapeutic effect of NPCT.

Place, publisher, year, edition, pages
BENTHAM SCIENCE PUBL , 2018. Vol. 17, no 2, p. 98-105
Keywords [en]
Mental retardation, neural precursor cell, transplantation, insulin-like growth factor 1, growth factors, intellectual disability
National Category
Neurology
Identifiers
URN: urn:nbn:se:uu:diva-359677DOI: 10.2174/1871527317666180411102337ISI: 000435906600004PubMedID: 29637872OAI: oai:DiVA.org:uu-359677DiVA, id: diva2:1245979
Funder
Swedish Research Council, 2710Available from: 2018-09-06 Created: 2018-09-06 Last updated: 2018-09-06Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records BETA

Sharma, ArunaSharma, Hari Shanker

Search in DiVA

By author/editor
Sharma, ArunaSharma, Hari Shanker
By organisation
Anaesthesiology and Intensive Care
In the same journal
CNS & Neurological Disorders: Drug Targets
Neurology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 8 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf